Quick Answer
Cardlytics, Inc. reported Total Revenue of $233.27 million for fiscal year 2025.
Cardlytics, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $233.27M -16.2% |
$278.30M -10.0% |
$309.20M +3.6% |
$298.54M +11.8% |
$267.12M +42.9% |
$186.89M -11.2% |
| Net Income | -$103.49M +45.3% |
-$189.30M -40.5% |
-$134.70M +71.0% |
-$465.26M -261.9% |
-$128.56M -132.0% |
-$55.42M -223.3% |
| Diluted EPS | -$1.95 +50.1% |
-$3.91 -6.0% |
-$3.69 +73.5% |
-$13.92 | — | — |
| Total Assets | $285.64M -27.3% |
$392.71M -31.6% |
$574.14M -16.9% |
$691.24M -45.3% |
$1.26B +199.1% |
$422.54M +88.4% |
| Cash and Equivalents | $48.72M -25.7% |
$65.59M -28.6% |
$91.83M -24.7% |
$121.91M -47.8% |
$233.47M -20.4% |
$293.24M +180.7% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | -$6.51M -109.3% |
$69.99M -48.1% |
$134.80M -36.3% |
$211.60M -69.4% |
$690.70M +339.4% |
$157.19M +9.7% |
| R&D Expense | $39.77M -19.8% |
$49.61M -3.4% |
$51.35M -5.7% |
$54.44M +42.9% |
$38.10M +117.3% |
$17.53M +49.9% |
| Operating Income | -$101.82M +47.9% |
-$195.50M -44.1% |
-$135.67M +70.4% |
-$457.78M -273.4% |
-$122.60M -127.4% |
-$53.92M -211.2% |
| Shares Outstanding | 54.51M +6.4% |
51.26M +29.0% |
39.73M | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $52.03M | -22.4% | -17.7% |
| Net Income | September 30, 2025 | -$72.67M | +49.9% | -682.9% |
| Diluted EPS | September 30, 2025 | -$1.36 | +53.1% | -655.6% |
| Total Assets | September 30, 2025 | $292.81M | -26.7% | -18.9% |
| Cash and Equivalents | September 30, 2025 | $43.96M | -34.4% | -6.0% |
| Long-Term Debt | September 30, 2020 | $0.00 | -100.0% | — |
| Stockholders Equity | September 30, 2025 | -$4.70M | -106.7% | -108.0% |
| R&D Expense | September 30, 2025 | $8.80M | -33.3% | -22.1% |
| Operating Income | September 30, 2025 | -$68.85M | +53.6% | -438.4% |
| Shares Outstanding | September 30, 2025 | 51.26M | +29.0% | +0.0% |
- Cardlytics, Inc. reported Total Revenue of $233.27 million for fiscal year 2025.
- Cardlytics, Inc. showed a decrease of -16.2% in Total Revenue compared to the prior fiscal year.
- Cardlytics, Inc. reported Net Income of -$103.49 million for fiscal year 2025.
- Cardlytics, Inc. showed an increase of +45.3% in Net Income compared to the prior fiscal year.
- Cardlytics, Inc. reported Diluted EPS of $1.95 per share (loss) for fiscal year 2025.
- Cardlytics, Inc. showed an increase of +50.1% in Diluted EPS compared to the prior fiscal year.
- Cardlytics, Inc. reported Total Assets of $285.64 million for fiscal year 2025.
- Cardlytics, Inc. showed a decrease of -27.3% in Total Assets compared to the prior fiscal year.
- Cardlytics, Inc. reported Cash and Equivalents of $48.72 million for fiscal year 2025.
- Cardlytics, Inc. showed a decrease of -25.7% in Cash and Equivalents compared to the prior fiscal year.
- Cardlytics, Inc. reported Long-Term Debt of $13.0 thousand for fiscal year 2019.
- Cardlytics, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Cardlytics, Inc. reported Stockholders Equity of -$6.51 million for fiscal year 2025.
- Cardlytics, Inc. showed a decrease of -109.3% in Stockholders Equity compared to the prior fiscal year.
- Cardlytics, Inc. reported R&D Expense of $39.77 million for fiscal year 2025.
- Cardlytics, Inc. showed a decrease of -19.8% in R&D Expense compared to the prior fiscal year.
- Cardlytics, Inc. reported Operating Income of -$101.82 million for fiscal year 2025.
- Cardlytics, Inc. showed an increase of +47.9% in Operating Income compared to the prior fiscal year.
- Cardlytics, Inc. reported Shares Outstanding of 54.51 million shares for fiscal year 2025.
- Cardlytics, Inc. showed an increase of +6.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: